The functional and mechanistic studies performed thus far further suggest that engagement of CD28-family molecules support an immediate, potent anti-tumor response whereas TNF-R superfamily molecules, namely, 4-1BB initiate lower-intensity signaling cascades which may contribute to gradual effector responses and sustained CAR-T cell proliferation. This evidence concerns the gene CD28 and neoplasm.